Bioactivty and controlled release studies of ranibizumab from polymeric carriers
Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in developed societies. Ranibizumab is an anti-angiogenic agent commonly prescribed to treat AMD. However several issues associated with its frequent intravitreal injections have intensified the need for a sustaine...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Theses and Dissertations |
| Language: | English |
| Published: |
2018
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10356/73341 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Nanyang Technological University |
| Language: | English |